Save time and get answers to complex questions with AI chat
Pramlintide acetate price?Atorvastatin side effects heart palpitations?When is tenofovir alafenamide patent expiring?Stribild expiry date?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for Xcopri
Xcopri (cenobamate) was approved by the U.S. Food and Drug Administration (FDA) on November 3, 2019. [1]
The FDA approval date above refers to Xcopri’s initial FDA approval for use in epilepsy. [1]
You can verify the FDA approval date for Xcopri on DrugPatentWatch.com: [1]
1
Other Questions About Xcopri :